IRIS - Res&Arch Institutional Research Information System - Research & Archive

TABILIO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.546
EU - Europa 2.023
AS - Asia 1.489
SA - Sud America 242
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.509
SG - Singapore 637
UA - Ucraina 452
IE - Irlanda 341
SE - Svezia 332
CN - Cina 244
BR - Brasile 210
HK - Hong Kong 208
DE - Germania 199
RU - Federazione Russa 189
VN - Vietnam 184
FI - Finlandia 145
IT - Italia 144
GB - Regno Unito 105
KR - Corea 101
TR - Turchia 30
FR - Francia 28
CA - Canada 18
IN - India 16
AT - Austria 14
AR - Argentina 13
CH - Svizzera 12
JP - Giappone 12
UZ - Uzbekistan 12
ZA - Sudafrica 12
MX - Messico 11
BD - Bangladesh 10
BE - Belgio 10
CZ - Repubblica Ceca 9
PL - Polonia 8
GR - Grecia 7
AZ - Azerbaigian 6
LB - Libano 6
NL - Olanda 6
RO - Romania 6
CL - Cile 5
IQ - Iraq 5
PY - Paraguay 5
EC - Ecuador 4
ES - Italia 4
LT - Lituania 4
PK - Pakistan 4
CO - Colombia 3
DZ - Algeria 3
EU - Europa 3
ID - Indonesia 3
MA - Marocco 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AU - Australia 2
JM - Giamaica 2
OM - Oman 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NR - Nauru 1
PT - Portogallo 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
YE - Yemen 1
Totale 6.330
Salva come PNG Salva come JPEG
Città #
Chandler 427
Singapore 419
Dublin 341
Jacksonville 246
San Mateo 243
Hong Kong 208
Ashburn 136
Boardman 132
Dong Ket 115
Seoul 101
Santa Clara 89
Medford 79
Beijing 78
Princeton 78
Ann Arbor 77
Wilmington 63
Andover 59
Moscow 48
Helsinki 43
Los Angeles 43
Munich 40
Piscataway 40
New York 35
Altamura 33
Shanghai 33
Lawrence 32
Woodbridge 29
Perugia 25
Izmir 22
Saint Petersburg 21
Turku 21
Houston 20
Ho Chi Minh City 19
Norwalk 18
Auburn Hills 16
Des Moines 15
Falkenstein 13
Hanoi 13
Dallas 12
São Paulo 12
Tokyo 12
Brooklyn 11
Council Bluffs 11
Brussels 10
Foligno 10
Johannesburg 10
Redwood City 10
Denver 8
San Paolo di Civitate 8
Brno 7
Chicago 7
Falls Church 7
London 7
Phoenix 7
Rio de Janeiro 7
Baku 6
Charlotte 6
Ankara 5
Belo Horizonte 5
Brasília 5
Chennai 5
Dearborn 5
Philadelphia 5
Rome 5
San Francisco 5
Curitiba 4
Frankfurt am Main 4
Haiphong 4
Montreal 4
Orem 4
Ottawa 4
Piediluco 4
Tashkent 4
The Dalles 4
Toronto 4
Warsaw 4
Bexley 3
Boston 3
Calarasi 3
Columbus 3
Den Haag 3
Dhaka 3
Guangzhou 3
Hangzhou 3
Hefei 3
Lahore 3
Lausanne 3
Mexico City 3
Milan 3
Osasco 3
Redmond 3
Roubaix 3
Stockholm 3
Tavernelle 3
Amsterdam 2
Asunción 2
Bogotá 2
Calgary 2
Campinas 2
Campos dos Goytacazes 2
Totale 3.788
Salva come PNG Salva come JPEG
Nome #
Sovraccarico di ferro in pazienti affetti da linfoma non Hodgkin (LNH) sottoposti a trapianto di midollo osseo autologo (A-TMO) ed emocromatosi ereditaria: esiste correlazione? Atti del IX Congresso Nazionale S.I.G.U. 170
Advances in full-haplotype mismatched transplants in acute leukemia 160
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 149
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 143
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 130
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 124
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 113
Graft engineering for allogeneic haploidentical stem cell transplantation 113
Mesenchymal cells: a vehicle for gene therapy 110
Fourth international workshop on haploidentical transplants, Naples, Italy 109
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 109
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 109
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 107
Modulating the gene silencing: novel insights to overcame gene therapy major limitation also in orthopaedic applications. 105
Recruitment of beta-hexosaminidase activity on plasma membrane and human T-cell activation-52° Congresso SIB 103
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 100
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 100
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 98
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 98
Characterization of a Unique Cd133+ Leukemia Cell Line Responsive to FGF2 and TGFb1 97
Transplants across human leukocyte antigen barriers 96
Histone deacetylation in retroviral driven transgene silencing: role of TSA as a pharmacological support for gene therapy 96
Plasma membrane associated beta-hexosaminidase activity increases during human T-cells activation 94
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 93
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 93
Decreased bone mineral density after autologous stem cell transplantation. 93
Allogeneic transplantation across the HLA barriers. 92
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 91
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 91
Haploidentical stem cell transplantation for acute leukemia 89
Characterization of human lysosomal α-D-mannosidase in leukaemic and non leukaemic cells 88
. Mismatched hematopoietic stem cell transplants in elderly patients. 88
Characterization of a unique CD133+leukemia cell line responsive to FGF2 and TGFbeta1 86
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 85
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 85
Mismatched hematopoietic stem cell transplantation in secondary leukemia 82
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 82
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 80
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 80
Stem cell mobilization in normal donors. 79
A mature thymocyte-like phenotypic pattern on human cord circulating T-lymphoid cells. 79
Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFbeta1 78
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 76
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 75
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 74
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 73
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 71
Full haplotype mismatched transplant in high risk acute leukemia patients. 71
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 69
High efficient gene transfer transduction using herpes simplex virus thymidine kinase (HSV-TK) gene: a comparison of different infection protocols. 69
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. 69
Diagnostic considerations on visceral leishmaniasis. Two case reports 69
Mesenchymal cells recruit and regulate T regulatory cells. 69
Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion based mechanism mediated by TNF-{alpha} 68
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 67
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation. 66
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 65
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 65
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 64
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 63
Implicazione della deacetilazione degli istoni nel silenziamento di transgeni veicolati tramite vettori retrovirali: ipotetico ruolo del TSA come supporto della terapia genica. 60
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 60
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 60
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection. 59
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase. 59
HSV-TK gene as a potential tool for gene generating a controlled graft-versus-host/graft-versus-leukemia effect 57
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 56
Eradication of B-CLL by Autologous and Allogeneic Host Non-Reactive Anti-Third Party CTLs. 55
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. 55
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 53
The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients. 53
Haematopoietic and Stromal Stem Cell Regulation by Extracellular Matrix Components and Growth Factors 51
Primary eyelid plasmacytoma. 50
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients. 45
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 44
Haploidentical stem cell transplantation in leukemia 44
Interleukin 7 retroviral gene transfer in human stromal cells enhances the survival of naive T lymphocyte. . 42
Homing and survival of thymidine kinase transduced T-limphocytes into NOD/SCID mice. 42
Totale 6.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.693
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021487 0 0 0 0 0 62 79 4 92 34 87 129
2021/2022774 18 196 32 71 33 6 10 217 3 7 94 87
2022/20231.200 87 161 3 122 98 141 0 60 476 3 30 19
2023/2024443 27 47 30 4 1 9 101 24 56 13 46 85
2024/20251.079 24 118 26 56 183 25 21 78 193 71 184 100
2025/20261.159 172 163 124 304 299 97 0 0 0 0 0 0
Totale 6.455